Skip to content
Open access

Child Opportunity Index and Survival After Pediatric Hematopoietic Cell Transplantation for Acute Leukemia

Sep 2026 · Transplantation and Cellular Therapy · 0 citations · 17 references
Medicine

TL;DR

In this single-institution cohort, children from very low opportunity neighborhoods experienced inferior survival after HCT for acute leukemia in exploratory analyses, and neighborhood opportunity should be investigated in larger, multi-institutional cohorts as a clinical risk factor for poor outcomes.

Abstract

Background: Despite advances in pediatric hematopoietic cell transplantation (HCT) for acute leukemia, many children still experience relapse and non-relapse mortality (NRM). Whether neighborhood socioeconomic context is a risk factor in pediatric HCT remains unclear. Objective: To evaluate the association between neighborhood opportunity, measured by the Child Opportunity Index (COI 3.0) and outcomes following first allogeneic HCT for pediatric acute leukemia. Study Design: We conducted a single-center retrospective cohort study of 147 children transplanted from 2012 to 2021. COI 3.0 is a validated composite measure of neighborhood-level resources and conditions capturing opportunities for child development. Primary analysis modeled COI as a five-level categorical exposure; exploratory analyses compared very low opportunity versus the remainder of the cohort. Outcomes included acute graft-versus-host disease (aGVHD), overall survival (OS), event-free survival (EFS), relapse, NRM, infections, and healthcare utilization. Results: In prespecified analyses, five-level neighborhood opportunity was not associated with clinical outcomes. In exploratory analyses, children in very low opportunity neighborhoods (N=30) experienced inferior OS compared with the remainder of the cohort (55% vs. 76%, p=0.01), after adjustment for detectable disease pre-HCT (adjusted HR 2.47, 95% CI 1.26-4.83, p=0.01). Relapse (37% vs. 28%) and NRM (10% vs. 7%) were higher among those in very low opportunity neighborhoods but were not statistically significant. No other differences were observed. Conclusions: In this single-institution cohort, children from very low opportunity neighborhoods experienced inferior survival after HCT for acute leukemia in exploratory analyses. Neighborhood opportunity should be investigated in larger, multi-institutional cohorts as a clinical risk factor for poor outcomes.

Read PDF

Similar papers

Open access Nov 2026

Risk-Adapted Donor Selection in Patients with Acute Myeloid Leukemia.

BACKGROUND The optimal donor for adults with acute myeloid leukemia (AML) who lack a matched sibling donor (MSD) remains uncertain in Asian practice, where antithymocyte globulin (ATG)-based graft-versus-host disease (GvHD) prophylaxis is common. OBJECTIVES To compare outcomes after MSD, matched unrelated donor (MUD)...

X. Tsai, Jia-Hau Liu, Liang-Tsai Hsiao et al. · 0 citations
Open access Sep 2026

Long-term survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia

Allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment for patients with higher-risk acute myeloid leukemia (AML), but survival is limited by recurrent malignancy and complications such as organ toxicity and infections. This study evaluated overall survival (OS) over the last two decades...

Alexandra Donschachner, G. Pregartner, B. Lindner et al. · 0 citations
Review Oct 2026

Predictive Factors for Intensive Care Unit Admission in Children and Young Adults Undergoing Hematopoietic Cell Transplantation.

Hematopoietic cell transplantation (HCT) carries significant morbidity and mortality. Defining factors that impact intensive care unit (ICU) admission rates in children and young adults undergoing HCT is required. Retrospective review of allogeneic (n=221) or autologous HCT (n=115) patients from 2013 to 2023 was comple...

Kayleigh M. Schwartz, Samantha Newman, Tzu-Hsuan Lin et al. · 0 citations
Oct 2026

Outcomes of Allogeneic Stem Cell Transplantation in a North American Adult T Cell Leukemia/Lymphoma Cohort.

The largest cohort evaluating HCT outcomes in a NA-ATLL population, evaluating 46 adult patients with NA-ATLL who underwent allogeneic HCT across participating North American centers suggests that fit patients should proceed to HCT expeditiously with any donor option available.

T. Wang, Julie Nguyen, Leticia Campoverde et al. · 0 citations
Oct 2026

Risk Factors for Admission to the Intensive Care Unit and Mortality in Allogeneic Hematopoietic Cell Transplant Recipients with Acute Myeloid Leukemia.

BACKGROUND Adults with acute myeloid leukemia (AML) are at risk of requiring intensive care unit (ICU)-level care following allogeneic hematopoietic cell transplantation (HCT). Risk factors for admission to the ICU and outcomes are, however, poorly defined. OBJECTIVE To assess risk factors associated with ICU admissi...

C. Orvain, M. Othus, A. Halpern et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.